RTO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 90 | |
PRICE GROWTH RATING 1..100 | 64 | |
P/E GROWTH RATING 1..100 | 46 | |
SEASONALITY SCORE 1..100 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EFAV | RTO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 61% | 1 day ago 79% |
| Stochastic ODDS (%) | 2 days ago 67% | 1 day ago 65% |
| Momentum ODDS (%) | 2 days ago 78% | 1 day ago 63% |
| MACD ODDS (%) | 2 days ago 79% | 1 day ago 60% |
| TrendWeek ODDS (%) | 2 days ago 76% | 1 day ago 58% |
| TrendMonth ODDS (%) | 2 days ago 72% | 1 day ago 59% |
| Advances ODDS (%) | 2 days ago 76% | 3 days ago 59% |
| Declines ODDS (%) | 23 days ago 75% | 1 day ago 58% |
| BollingerBands ODDS (%) | 2 days ago 66% | 1 day ago 60% |
| Aroon ODDS (%) | 2 days ago 76% | 1 day ago 51% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EQIN | 52.93 | 0.08 | +0.14% |
| Columbia US Equity Income ETF | |||
| LYFX | 7.92 | N/A | N/A |
| Tradr 2X Long LYFT Daily ETF | |||
| ETG | 23.61 | -0.02 | -0.08% |
| Eaton Vance Tax-Advantaged Global Dividend Income Fund | |||
| OVF | 31.31 | -0.04 | -0.13% |
| Overlay Shares Foreign Equity ETF | |||
| NPCT | 9.70 | -0.02 | -0.21% |
| Nuveen Core Plus Impact Fund | |||
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with RIO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then RIO could also see price increases.
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | -1.09% | ||
| RIO - EFAV | 50% Loosely correlated | -0.34% | ||
| SAN - EFAV | 49% Loosely correlated | -0.07% | ||
| RTO - EFAV | 44% Loosely correlated | -3.67% | ||
| GSK - EFAV | 43% Loosely correlated | -0.73% | ||
| HLN - EFAV | 39% Loosely correlated | -2.37% | ||
More | ||||